Literature DB >> 11443184

Missense mutations cluster within the carboxyl-terminal region of DAX-1 and impair transcriptional repression.

J C Achermann1, M Ito, B L Silverman, R L Habiby, S Pang, A Rosler, J L Jameson.   

Abstract

DAX-1 is an orphan nuclear receptor that plays a key role in the development and function of the adrenal gland and hypothalamic-pituitary gonadal axis. Mutations in the gene encoding DAX-1 result in X-linked adrenal hypoplasia congenita (AHC). Affected boys typically present with primary adrenal failure in infancy or childhood and hypogonadotropic hypogonadism at the time of puberty. The majority of DAX1 mutations described to date are nonsense or frameshift mutations that result in premature truncation of the DAX-1 protein and loss of DAX-1 repressor function. Relatively few missense mutations in DAX1 have been reported. Here, we describe missense mutations in three additional families with X-linked AHC. When combined with previous reports, the DAX1 missense mutations appear to cluster within restricted regions of the putative ligand-binding domain of DAX-1 and affect amino acids that are evolutionarily conserved, suggesting that these regions correspond to critical functional domains. Transcription assays, using a variety of artificial and native target genes, were performed to assess the effects of these mutations on the function of DAX-1. All DAX-1 missense mutant constructs showed marked loss of repressor function, with the exception of I439S, a mutation previously shown to be associated with delayed-onset adrenal failure and incomplete hypogonadotropic hypogonadism. These data indicate that most DAX1 missense mutations associated with classic AHC exhibit marked loss of function. The locations of these mutations thereby identify important functional domains in the carboxyl-terminus of the protein.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11443184     DOI: 10.1210/jcem.86.7.7660

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  19 in total

1.  X-linked adrenal hypoplasia congenita is caused by abnormal nuclear localization of the DAX-1 protein.

Authors:  Sylvia G Lehmann; Enzo Lalli; Paolo Sassone-Corsi
Journal:  Proc Natl Acad Sci U S A       Date:  2002-05-28       Impact factor: 11.205

2.  A novel missense mutation in DAX-1 with an unusual presentation of X-linked adrenal hypoplasia congenita.

Authors:  Imran Ahmad; Wendy F Paterson; Lin Lin; Peter Adlard; Philippa Duncan; John Tolmie; John C Achermann; Malcolm D C Donaldson
Journal:  Horm Res       Date:  2007-02-16

3.  NR0B1 (DAX1) mutations in patients affected by congenital adrenal hypoplasia with growth hormone deficiency as a new finding.

Authors:  Aleksandra Rojek; Monika Obara-Moszynska; Elzbieta Malecka; Malgorzata Slomko-Jozwiak; Marek Niedziela
Journal:  J Appl Genet       Date:  2013-02-02       Impact factor: 3.240

4.  Mutational analysis of steroidogenic factor 1 (NR5a1) in 24 boys with bilateral anorchia: a French collaborative study.

Authors:  Pascal Philibert; Delphine Zenaty; Lin Lin; Sylvie Soskin; Françoise Audran; Juliane Léger; John C Achermann; Charles Sultan
Journal:  Hum Reprod       Date:  2007-10-16       Impact factor: 6.918

Review 5.  Battle of the sexes: new insights into genetic pathways of gonadal development.

Authors:  J Larry Jameson; John C Achermann; Gokhan Ozisik; Joshua J Meeks
Journal:  Trans Am Clin Climatol Assoc       Date:  2003

6.  X-linked adrenal hypoplasia congenita and hypogonadotropic hypogonadism: report on new mutation of the DAX-1 gene in two siblings.

Authors:  V Calvari; M G Alpigiani; E Poggi; B Podesta; G Camerino; R Lorini
Journal:  J Endocrinol Invest       Date:  2006-01       Impact factor: 4.256

7.  Infantile Growth Hormone Deficiency and X- Linked Adrenal Hypoplasia Congenita.

Authors:  Stephanie T Chung; Carolyn H Chi; Morey W Haymond; George S Jeha
Journal:  Jacobs J Pediatr       Date:  2015-05-04

Review 8.  Genetic disorders of nuclear receptors.

Authors:  John C Achermann; John Schwabe; Louise Fairall; Krishna Chatterjee
Journal:  J Clin Invest       Date:  2017-04-03       Impact factor: 14.808

9.  Analysis of DAX1 (NR0B1) and steroidogenic factor-1 (NR5A1) in children and adults with primary adrenal failure: ten years' experience.

Authors:  Lin Lin; Wen-Xia Gu; Gokhan Ozisik; Wing S To; Catherine J Owen; J Larry Jameson; John C Achermann
Journal:  J Clin Endocrinol Metab       Date:  2006-05-09       Impact factor: 5.958

10.  CBP/p300-interacting transactivator, with Glu/Asp-rich C-terminal domain, 2, and pre-B-cell leukemia transcription factor 1 in human adrenal development and disease.

Authors:  Bruno Ferraz-de-Souza; Franziska Martin; Delphine Mallet; Rebecca E Hudson-Davies; Patricia Cogram; Lin Lin; Dianne Gerrelli; Felix Beuschlein; Yves Morel; Angela Huebner; John C Achermann
Journal:  J Clin Endocrinol Metab       Date:  2008-11-04       Impact factor: 5.958

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.